It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt. An FDA advisory committee ...

Node.js v4 or later. Splunk logging for Javascript is tested with Node.js v10.0 and v14.0. Splunk Enterprise 6.3.0 or later, or Splunk Cloud. Splunk logging for Javascript is tested with Splunk ...

Get the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock news and headlines to help you in your trading and investing decisions.

Get the latest news and real-time alerts from Lexicon Pharmaceuticals, Inc. (LXRX) stock at Seeking Alpha.

Discover historical prices for LXRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Lexicon Pharmaceuticals, Inc. stock was issued.

Chart does not reflect overnight price.

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...